Inspire Advisors LLC raised its position in shares of Varex Imaging Co. (NASDAQ:VREX – Free Report) by 22.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 17,334 shares of the company’s stock after buying an additional 3,185 shares during the quarter. Inspire Advisors LLC’s holdings in Varex Imaging were worth $253,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of VREX. Empowered Funds LLC lifted its position in shares of Varex Imaging by 5.3% during the third quarter. Empowered Funds LLC now owns 158,873 shares of the company’s stock valued at $1,894,000 after buying an additional 8,040 shares during the last quarter. Quest Partners LLC purchased a new stake in shares of Varex Imaging during the third quarter valued at about $41,000. LMR Partners LLP purchased a new stake in shares of Varex Imaging during the third quarter valued at about $243,000. Factorial Partners LLC purchased a new stake in shares of Varex Imaging during the third quarter valued at about $399,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Varex Imaging during the third quarter valued at about $312,000.
Varex Imaging Stock Performance
VREX opened at $12.55 on Thursday. Varex Imaging Co. has a 52-week low of $10.19 and a 52-week high of $18.30. The company has a quick ratio of 2.50, a current ratio of 4.36 and a debt-to-equity ratio of 1.02. The company has a market cap of $517.06 million, a P/E ratio of -10.73 and a beta of 0.56. The firm’s 50-day moving average price is $13.46 and its 200-day moving average price is $13.40.
Analysts Set New Price Targets
Several analysts have commented on VREX shares. StockNews.com raised shares of Varex Imaging from a “hold” rating to a “buy” rating in a research report on Friday, February 7th. B. Riley restated a “buy” rating and set a $22.00 price objective (up previously from $21.00) on shares of Varex Imaging in a report on Friday, February 7th. Finally, Oppenheimer cut their price objective on shares of Varex Imaging from $30.00 to $23.00 and set an “outperform” rating on the stock in a report on Friday, February 7th.
Check Out Our Latest Stock Analysis on VREX
About Varex Imaging
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Further Reading
- Five stocks we like better than Varex Imaging
- How to Profit From Value Investing
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- 3 Grocery Stocks That Are Proving They Are Still Essential
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Canadian Penny Stocks: Can They Make You Rich?
- Why Energy Transfer Belongs on Your Watchlist
Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging Co. (NASDAQ:VREX – Free Report).
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.